Literature DB >> 12297399

Comparison of the bioactivity of reference preparations for assaying Bordetella pertussis toxin activity in vaccines by the histamine sensitisation and Chinese hamster ovary-cell tests: assessment of validity of expression of activity in terms of protein concentration.

D Xing1, R Gaines Das, P Newland, M Corbel.   

Abstract

Pertussis toxin (PT) in its detoxified form is an important antigenic component of both acellular and whole cell pertussis vaccines. Limits on the content of active PT in acellular vaccines are set in official monographs (EP, WHO, USP) and evidence of compliance is therefore, required by regulatory authorities. The two assay methods which are currently used by most manufacturers and official national control laboratories to monitor residual PT activity in acellular pertussis vaccines (and also in whole cell vaccines) are histamine sensitising (HIST) assays and Chinese hamster ovary (CHO) cell assays. Currently, different reference preparations of PT are used by individual laboratories for these tests. We therefore organised an international collaborative study to examine, by these two assay methods, two freeze-dried purified preparations of PT, one preparation in ampoules coded JNIH-5 and one preparation in ampoules coded 90/518, together with in-house reference (IHR) preparations in current use. Data from this study confirm that both JNIH-5 and 90/518 show biological activity both in HIST assays and in CHO-cell assays. Both HSD50 and ED50 values obtained in this study differ significantly between laboratories and thus show that biological activity is not determined by the nominal masses of preparations. Estimates of relative potency of 90/518 in terms of JNIH-5 per ampoule for the HIST assays do not differ significantly between laboratories. The overall mean estimates of relative potency of 90/518 in terms of JNIH-5 do not differ significantly between the two methods. Data from this study further indicate that the biological activity of different preparations was not directly related to their stated protein content. The use of protein content to indicate the level of PT activity in different preparations would give misleading results. Thus, use of a common standard is shown to greatly improve between laboratory agreement of estimates.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12297399     DOI: 10.1016/s0264-410x(02)00338-9

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  7 in total

1.  Investigation in a murine model of possible mechanisms of enhanced local reactions to post-primary diphtheria-tetanus toxoid boosters in recipients of acellular pertussis-diphtheria-tetanus vaccine.

Authors:  Masaki Ochiai; Yoshinobu Horiuchi; Chun-Ting Yuen; Catpagavalli Asokanathan; Akihiko Yamamoto; Kenji Okada; Michiyo Kataoka; Kevin Markey; Michael Corbel; Dorothy Xing
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

2.  Alternatives to HIST for acellular pertussis vaccines: progress and challenges in replacement.

Authors:  J Arciniega; L Wagner; R Prymula; P Sebo; R Isbrucker; B Descampe; J M Chapsal; A Costanzo; C Hendriksen; M Hoonaker; S Nelson; K Lidster; W Casey; D Allen
Journal:  Pharmeur Bio Sci Notes       Date:  2016

3.  Pertussis serology: assessment of IgG anti-PT ELISA for replacement of the CHO cell assay.

Authors:  Tine Dalby; Charlotte Sørensen; Jesper Westphal Petersen; Karen Angeliki Krogfelt
Journal:  APMIS       Date:  2010-09-02       Impact factor: 3.205

Review 4.  Assays for Determining Pertussis Toxin Activity in Acellular Pertussis Vaccines.

Authors:  Kevin Markey; Catpagavalli Asokanathan; Ian Feavers
Journal:  Toxins (Basel)       Date:  2019-07-17       Impact factor: 4.546

5.  The CHO Cell Clustering Response to Pertussis Toxin: History of Its Discovery and Recent Developments in Its Use.

Authors:  Mary C Gray; Richard L Guerrant; Erik L Hewlett
Journal:  Toxins (Basel)       Date:  2021-11-19       Impact factor: 4.546

Review 6.  In Vivo Models and In Vitro Assays for the Assessment of Pertussis Toxin Activity.

Authors:  Marieke Esther Hoonakker
Journal:  Toxins (Basel)       Date:  2021-08-12       Impact factor: 4.546

7.  iGIST-A Kinetic Bioassay for Pertussis Toxin Based on Its Effect on Inhibitory GPCR Signaling.

Authors:  Valeriy M Paramonov; Cecilia Sahlgren; Adolfo Rivero-Müller; Arto T Pulliainen
Journal:  ACS Sens       Date:  2020-11-04       Impact factor: 7.711

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.